STAT Plus: Sanofi pulls Zantac from the U.S., joining a growing list of companies recalling heartburn meds
The drug maker explained the recall is taking place now as a “precautionary measure” due to “possible contamination” caused by an impurity called NDMA.
No hay comentarios:
Publicar un comentario